Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common stock
Additional paid-in capital
Subscriptions payable
Accumulated deficit
Total
Balances at Dec. 31, 2020 $ 85 $ 9,896 $ 25,920,858 $ (20,196,823) $ 5,734,016
Balances (in Shares) at Dec. 31, 2020 84,872 9,895,600        
Conversion of Series A Convertible Preferred Stock into common stock $ (20) $ 53 (33)
Conversion of Series A Convertible Preferred Stock into common stock (in Shares) (20,000) 72,369        
Shares issued for vested restricted stock units $ 97 132,460 132,557
Shares issued for vested restricted stock units (in Shares) 96,757        
Shares issued for vested restricted stock units $ 272 (272)
Shares issued for vested restricted stock units (in Shares) 272,164        
Shares issued for equity financing $ 72 249,928 250,000
Shares issued for equity financing (in Shares) 52,632        
Stock based compensation 1,230,362 1,230,362
Net Loss (1,993,487) (1,993,487)
Balances at Jun. 30, 2021 $ 65 $ 10,390 27,533,303 (22,190,310) 5,353,448
Balances (in Shares) at Jun. 30, 2021 64,872 10,389,522        
Balances at Mar. 31, 2021 $ 65 $ 10,030 26,671,462 (20,944,766) 5,736,791
Balances (in Shares) at Mar. 31, 2021 64,872 10,029,433        
Shares issued as settlement of accounts payable $ 97 132,460 132,557
Shares issued as settlement of accounts payable (in Shares) 96,757        
Shares issued for vested restricted stock units $ 263 (263)
Shares issued for vested restricted stock units (in Shares) 263,332        
Stock based compensation 729,644 729,644
Net Loss (1,245,544) (1,245,544)
Balances at Jun. 30, 2021 $ 65 $ 10,390 27,533,303 (22,190,310) 5,353,448
Balances (in Shares) at Jun. 30, 2021 64,872 10,389,522        
Balances at Dec. 31, 2021 $ 40 $ 11,293 29,805,028 600,000 (24,011,291) 6,405,070
Balances (in Shares) at Dec. 31, 2021 39,810 11,293,030        
Shares issued as settlement of accounts payable $ 84 84,916 85,000
Shares issued as settlement of accounts payable (in Shares) 83,954        
Shares issued for vested restricted stock units $ 72 (72)
Shares issued for vested restricted stock units (in Shares) 71,666        
Commitment shares issued in conjunction with capital raise $ 278 199,722 200,000
Commitment shares issued in conjunction with capital raise (in Shares) 277,778        
Stock based compensation 645,549 645,549
Net Loss   (1,189,909) (1,189,909)
Balances at Jun. 30, 2022 $ 40 $ 11,727 30,735,143 600,000 (25,201,200) 6,145,710
Balances (in Shares) at Jun. 30, 2022 39,810 11,726,428        
Balances at Mar. 31, 2022 $ 40 $ 11,396 30,237,493 600,000 (24,637,837) 6,211,092
Balances (in Shares) at Mar. 31, 2022 39,810 11,395,650        
Conversion of Series A Convertible Preferred Stock into common stock
Conversion of Series A Convertible Preferred Stock into common stock (in Shares)        
Shares issued as settlement of accounts payable
Shares issued as settlement of accounts payable (in Shares)        
Shares issued for common stock placement
Shares issued for vested restricted stock units $ 53 (53)
Shares issued for vested restricted stock units (in Shares) 53,000        
Costs of equity raise $ 278 199,722 200,000
Commitment shares issued in conjunction with capital raise (in Shares)   277,778        
Stock based compensation 297,981 297,981
Net Loss (563,363) (563,363)
Balances at Jun. 30, 2022 $ 40 $ 11,727 $ 30,735,143 $ 600,000 $ (25,201,200) $ 6,145,710
Balances (in Shares) at Jun. 30, 2022 39,810 11,726,428